These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

130 related items for PubMed ID: 7627706

  • 21. Inhibitor analysis of LDL-induced platelet aggregation.
    Vlasova II, Azizova OA, Lopukhin YuM.
    Biochemistry (Mosc); 1997 Mar; 62(3):307-11. PubMed ID: 9275303
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Reversal by high-density lipoprotein of the effect of oxidized low-density lipoprotein on nitric oxide synthase protein expression in human platelets.
    Mehta JL, Chen LY.
    J Lab Clin Med; 1996 Mar; 127(3):287-95. PubMed ID: 9273362
    [Abstract] [Full Text] [Related]

  • 24. Acetyl glycerylphosphorylcholine aggregates human platelets through two distinct pathways, both dependent on arachidonic acid metabolism.
    Macconi D, Morzenti G, Livio M, Morelli C, Cassina G, Remuzzi G.
    Lab Invest; 1985 Feb; 52(2):159-68. PubMed ID: 3155816
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. The effect of oxidatively modified low-density lipoproteins on platelet aggregability and membrane fluidity.
    Vlasova II.
    Platelets; 2000 Nov; 11(7):406-14. PubMed ID: 11132108
    [Abstract] [Full Text] [Related]

  • 28. Anti-inflammatory and platelet anti-aggregant activity of phospholipase-A2 inhibitors.
    Vallee E, Gougat J, Navarro J, Delahayes JF.
    J Pharm Pharmacol; 1979 Sep; 31(9):588-92. PubMed ID: 41058
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Modified forms of low density lipoprotein affect platelet aggregation in vitro.
    Aviram M.
    Thromb Res; 1989 Mar 15; 53(6):561-7. PubMed ID: 2734732
    [Abstract] [Full Text] [Related]

  • 33. Arachidonate metabolism, 5-hydroxytryptamine release and aggregation in human platelets activated by palmitaldehyde acetal phosphatidic acid.
    Brammer JP, Maguire MH.
    Br J Pharmacol; 1984 May 15; 82(1):61-72. PubMed ID: 6428500
    [Abstract] [Full Text] [Related]

  • 34. Participation of the arachidonic acid cascade pathway in macrophage binding/uptake of oxidized low density lipoprotein.
    Beppu M, Watanabe M, Sunohara M, Ohishi K, Mishima E, Kawachi H, Fujii M, Kikugawa K.
    Biol Pharm Bull; 2002 Jun 15; 25(6):710-7. PubMed ID: 12081134
    [Abstract] [Full Text] [Related]

  • 35. Lysine modification of LDL or lipoprotein(a) by 4-hydroxynonenal or malondialdehyde decreases platelet serotonin secretion without affecting platelet aggregability and eicosanoid formation.
    Malle E, Ibovnik A, Leis HJ, Kostner GM, Verhallen PF, Sattler W.
    Arterioscler Thromb Vasc Biol; 1995 Mar 15; 15(3):377-84. PubMed ID: 7749848
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.